Study Title
Yttrium-90 Radiation Lobectomy: Dose Optimization and Prediction of FLR Hypertrophy to Enable Resection of HCC
Study Details
Description:
HCC resection candidates with inadequate future liver remnant will be enrolled in this study. They will be treated with Y90 radioembolization to help grow the liver enough to undergo liver resection. There will be 2 Patient Groups. The first group of patients will be treated with Y90 dose and embolic load as per standard-of-care. The second group of patients will be treated with the optimal Y90 dose and embolic load found in Patient Group 1.
Sponsor:
Northwestern UniversityContacts:
Robert Lewandowski, MD (Principal Investigator)r-lewandowki@northwestern.edu
312-695-9121
Kristie Kennedy, MAkristie.kennedy@northwestern.edu
312-695-4023
Government Study Link:
NCT04390724 - Click here to see study onClinicalTrials.gov
© 2021 XCancer Software LLC
Contact XCancer: 402-991-8468